This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jan;4(1):21-22.

doi: 10.1016/S2215-0366(16)30372-8.

DSM-III-R change in definition might have affected placebo response to antidepressants

Konstantinos N Fountoulakis¹

Affiliations

PMID: 28012476
DOI: 10.1016/S2215-0366(16)30372-8

Comment

DSM-III-R change in definition might have affected placebo response to antidepressants

Konstantinos N Fountoulakis. Lancet Psychiatry. 2017 Jan.

. 2017 Jan;4(1):21-22.

doi: 10.1016/S2215-0366(16)30372-8.

Author

Konstantinos N Fountoulakis¹

Affiliation

¹ 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki 55535. Electronic address: greecekfount@med.auth.gr.

PMID: 28012476
DOI: 10.1016/S2215-0366(16)30372-8

No abstract available

PubMed Disclaimer

Comment on

Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies.
Furukawa TA, Cipriani A, Atkinson LZ, Leucht S, Ogawa Y, Takeshima N, Hayasaka Y, Chaimani A, Salanti G. Furukawa TA, et al. Lancet Psychiatry. 2016 Nov;3(11):1059-1066. doi: 10.1016/S2215-0366(16)30307-8. Epub 2016 Oct 7. Lancet Psychiatry. 2016. PMID: 27726982

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information